首页> 外文会议>Workshop on Advanced Research and Technology in Industry Applications >Study on the Application of P16/KI67 Protein in Screening of Cervical Cancer
【24h】

Study on the Application of P16/KI67 Protein in Screening of Cervical Cancer

机译:P16 / KI67蛋白在宫颈癌筛选中的应用研究

获取原文

摘要

Cervical cancer is one of the most common malignant tumors of the gynecological department. In recent years, there has been a tendency to report the incidence of cervical cancer at home and abroad. The incidence of cervical cancer under 35 years of age is increasing, which seriously endangers women's health. Screening and prevention of cervical cancer is of great importance. The cervical intraepithelial neoplasia is a general term for a group of precancerous lesions closely related to cervical cancer, including cervical epithelial dysplasia and cervical carcinoma (CIS). It reflects the continuous development of cervical cancer development process, this period lasted for a long time, up to 10-20 years, and from atypical hyperplasia of cervix to carcinoma in situ and invasive cancer is a long-term development process, to prevent the occurrence of cervical cancer, The key is cervical screening of cervical intraepithelial neoplasia.
机译:宫颈癌是妇科部门最常见的恶性肿瘤之一。近年来,倾向于在国内外报告宫颈癌发病率。 35岁以下的宫颈癌的发病率正在增加,这严重危及妇女的健康。筛查和预防宫颈癌具有重要意义。宫颈上皮内瘤周期是一组与宫颈癌密切相关的一组癌前病变的一般术语,包括宫颈上皮发育不良和宫颈癌(CIS)。它反映了宫颈癌开发过程的不断发展,这一时期持续了很长时间,高达10 - 20年,从子宫颈的非典型增生到原位和侵入性癌症是一个长期的发展过程,防止了宫颈癌的发生,关键是宫颈上皮内瘤周期的宫颈筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号